| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.4M | — | +1.9% |
| R&D Expense | $20.6M | — | -42.0% |
| SG&A Expense | $8.1M | — | -17.1% |
| Operating Income | -$26.3M | — | +38.8% |
| Income Tax | $0 | — | — |
| Net Income | -$25.1M | — | +37.3% |
| EPS (Basic) | -$0.26 | — | +39.5% |
| EPS (Diluted) | -$0.26 | — | +39.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.1M | -2.5% | -59.0% |
| Accounts Receivable | $227K | +229.0% | +158.0% |
| Current Assets | $122.4M | -15.7% | -43.7% |
| Total Assets | $149.0M | -15.0% | -45.6% |
| Current Liabilities | $19.7M | -22.6% | -31.0% |
| Total Liabilities | $47.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$27.0M | — | +26.5% |
| Capital Expenditures | $72K | — | -93.1% |
| Investing Cash Flow | $24.0M | — | -51.4% |
| Financing Cash Flow | $2.7M | — | +476.1% |
| Free Cash Flow | -$27.1M | — | +28.4% |
| -16.8% |
| Stockholders' Equity | $102.0M | -16.5% | -53.0% |